UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Secondary KIT mutations: the GIST of drug resistance and sensitivity

British journal of cancer, 2019-03, Vol.120 (6), p.577-578

2019

Volltextzugriff (PDF)

Anoikis Resistance as a Further Trait of Acidic-Adapted Melanoma Cells

Journal of oncology, 2019-01, Vol.2019 (2019), p.1-13

2019

Volltextzugriff (PDF)

Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature

Journal of oncology, 2022-04, Vol.2022, p.1539659-19

2022

Volltextzugriff (PDF)

Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Journal of oncology, 2022-03, Vol.2022, p.2724476-7

2022

Volltextzugriff (PDF)

Impact of Platelets to Lymphocytes Ratio and Lymphocytes during Radical Concurrent Radiotherapy and Chemotherapy on Patients with Nonmetastatic Esophageal Squamous Cell Carcinoma

Journal of oncology, 2022, Vol.2022, p.3412349-12

2022

Volltextzugriff (PDF)

Could a Personalized Strategy Using Accelerated Partial Breast Irradiation be an Advantage for Elderly Patients? A Systematic Review of the Literature and Multidisciplinary Opinion

Journal of oncology, 2020, Vol.2020 (2020), p.1-7

2020

Volltextzugriff (PDF)

Enchondroma versus Chondrosarcoma in Long Bones of Appendicular Skeleton: Clinical and Radiological Criteria-A Follow-Up

Journal of Oncology, 2016-01, Vol.2016 (2016), p.29-38

2016

Volltextzugriff (PDF)

Protumor Activities of the Immune Response: Insights in the Mechanisms of Immunological Shift, Oncotraining, and Oncopromotion

Journal of Oncology, 2013-01, Vol.2013 (2013), p.194-209

2013

Volltextzugriff (PDF)

Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients

Journal of Oncology, 2014-01, Vol.2014 (2014), p.130-135

2014

Volltextzugriff (PDF)

Evolving Concepts: Immunity in Oncology from Targets to Treatments

Journal of Oncology, 2015-01, Vol.2015 (2015), p.253-267

2015

Volltextzugriff (PDF)

Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples

Journal of experimental & clinical cancer research, 2020-05, Vol.39 (1), p.95-95, Article 95

2020

Volltextzugriff (PDF)

Do Diametric Measurements Provide Sufficient and Reliable Tumor Assessment? An Evaluation of Diametric, Areametric, and Volumetric Variability of Lung Lesion Measurements on Computerized Tomography Scans

Journal of Oncology, 2015-01, Vol.2015 (2015), p.225-230

2015

Volltextzugriff (PDF)

Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients

Journal of Oncology, 2013-01, Vol.2013 (2013), p.34-41

2013

Volltextzugriff (PDF)

Comparison of Short and Continuous Hydration Regimen in Chemotherapy Containing Intermediate- to High-Dose Cisplatin

Journal of Oncology, 2014-01, Vol.2014 (2014), p.136-139

2014

Volltextzugriff (PDF)

An International Survey of Health Care Providers Involved in the Management of Cancer Patients Exposed to Cardiotoxic Therapy

Journal of Oncology, 2015-01, Vol.2015 (2015), p.174-177

2015

Volltextzugriff (PDF)

Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions

Oncogene, 2021-02, Vol.40 (7), p.1284-1299

2021

Volltextzugriff (PDF)

Immunotherapy in Hepatocellular Carcinoma

Current treatment options in oncology, 2021-10, Vol.22 (10), p.87, Article 87

2021

Volltextzugriff (PDF)

Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis

Critical reviews in oncology/hematology, 2016-03, Vol.99, p.150-157

2016

Volltextzugriff (PDF)

Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma

Journal of Oncology, 2015-01, Vol.2015 (2015), p.370-375

2015

Volltextzugriff (PDF)

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Cancer, 2020-06, Vol.126 (11), p.2637-2647

2020

Volltextzugriff (PDF)

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis

PloS one, 2015-07, Vol.10 (7), p.e0133488-e0133488

2015

Volltextzugriff (PDF)

Effects of KRAS, BRAF, NRAS , and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

The lancet oncology, 2010-08, Vol.11 (8), p.753-762

2010

Volltextzugriff (PDF)

The Efficacy of Bisphosphonates in Preventing Aromatase Inhibitor Induced Bone Loss for Postmenopausal Women with Early Breast Cancer: A Systematic Review and Meta-Analysis

Journal of Oncology, 2014-01, Vol.2014 (2014), p.104-116

2014

Volltextzugriff (PDF)

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

Cancer Immunology, Immunotherapy, 2022-04, Vol.71 (4), p.865-874

2022

Volltextzugriff (PDF)

Proteomics of Uveal Melanoma: A Minireview

Journal of Oncology, 2013-01, Vol.2013 (2013), p.43-53

2013

Volltextzugriff (PDF)

1 – 25 von 567

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(516)
Mit Volltextzugriff
(469)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(69)
Journal Of Oncology
(26)
Cancer
(13)
Clinical Cancer Research
(12)
Critical Reviews In Oncology/hematology
(12)
Therapeutic Advances In Medical Oncology
(12)
Cancers
(10)
Oncology
(10)
Chemotherapy
(9)
Future Oncology
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Secondary KIT mutations: the GIST of drug resistance and sensitivity

Anoikis Resistance as a Further Trait of Acidic-Adapted Melanoma Cells

Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature

Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Impact of Platelets to Lymphocytes Ratio and Lymphocytes during Radical Concurrent Radiotherapy and Chemotherapy on Patients with Nonmetastatic Esophageal Squamous Cell Carcinoma

Could a Personalized Strategy Using Accelerated Partial Breast Irradiation be an Advantage for Elderly Patients? A Systematic Review of the Literature and Multidisciplinary Opinion

Enchondroma versus Chondrosarcoma in Long Bones of Appendicular Skeleton: Clinical and Radiological Criteria-A Follow-Up

Protumor Activities of the Immune Response: Insights in the Mechanisms of Immunological Shift, Oncotraining, and Oncopromotion

Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients

Evolving Concepts: Immunity in Oncology from Targets to Treatments

Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples

Do Diametric Measurements Provide Sufficient and Reliable Tumor Assessment? An Evaluation of Diametric, Areametric, and Volumetric Variability of Lung Lesion Measurements on Computerized Tomography Scans

Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients

Comparison of Short and Continuous Hydration Regimen in Chemotherapy Containing Intermediate- to High-Dose Cisplatin

An International Survey of Health Care Providers Involved in the Management of Cancer Patients Exposed to Cardiotoxic Therapy

Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions

Immunotherapy in Hepatocellular Carcinoma

Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis

Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis

Effects of KRAS, BRAF, NRAS , and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

The Efficacy of Bisphosphonates in Preventing Aromatase Inhibitor Induced Bone Loss for Postmenopausal Women with Early Breast Cancer: A Systematic Review and Meta-Analysis

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

Proteomics of Uveal Melanoma: A Minireview

Suchergebnisse filtern